Buspirone increases social investigation in pair-housed male mice; comparison with the effects of chlordiazepoxide

Neuropharmacology

Volumn 32, Issue 5, 1993, Pages 429-437

  Gao, B ^a   Cutler, M G ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

anxiolytic; buspirone; chlordiazepoxide; mouse; social behaviour

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; CHLORDIAZEPOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; TRANQUILIZING ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; TIME;

ANALYSIS OF VARIANCE; ANIMAL; BUSPIRONE; CHLORDIAZEPOXIDE; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; SOCIAL BEHAVIOR; TIME FACTORS;

EID: 0027336681     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(93)90166-Z     Document Type: Article

References (42)

1. Behavioural studies with anxiolytic drugs. III. Antipunishment action of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms
2. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone
3. Animal models of anxiety; the effect of compounds that modify 5-HT neurotransmission
4. 2 receptors
5. Actions of buspirone in a putative model of anxiety in the mouse
6. 3 receptor antagonists, BRL 43694 and ICS 205–930, under circumstances of high and low light intensity
7. 3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice
8. Effects of ipsapirone on the behaviour of mice during social encounters
9. 3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil
10. Ethopharmacology: a biological approach to the study of drug-induced changes in behavior
11. Effects of lead in the laboratory mouse—2. Development and social behaviour after lifelong administration of a small dose of lead acetate in drinking fluid
12. 3 receptor agonists and NMDA receptor antagonists in the social interaction test and elevated plus-maze
13. Buspirone; review of its pharmacology and current perspectives on its mechanism of action
14. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs
15. Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour
16. Behavioural pharmacology of minor tranquillizers
17. 3 receptor antagonist, BRL 46470, on the behaviour of mice
18. Effects of acute and subchronic administration of propranolol on the social behaviour of mice; an ethopharmacological study
19. 3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two-compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage
20. Effects of acute and subchronic administration of ritanserin on the social behaviour of mice
21. Recent developments in 5-HT-related pharmacology of animal models of anxiety
22. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
23. Pharmacological characterisation of a modified social interaction model of anxiety in the rat
24. Behavioral analysis of diazepam-induced memory deficits: evidence for sedation-like effects
25. Intrahippocampal buspirone in animal models of anxiety
26. Can social and agonistic interactions be used to detect anxiolytic activity of drugs?
27. Drug treatment of anxiety; implications for animal models
28. Behavioural analogues of anxiety. Animal models
29. Behav. Pharmac.
30. 1A receptor ligands
31. The psychopharmacology of aggression
32. Pro-aggressive actions of benzodiazepines
33. Modulatory actions of benzodiazepine receptor ligands on agonistic behaviour
34. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone
35. Benzodiazepine dependence: a review of the evidence
36. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat
37. Animal models of anxiety and the development of novel anxiolytic drugs
38. Anti-conflict efficacy of buspirone following acute versus chronic treatment
39. Serotonin agents in anxiety
40. Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?
41. 1A-receptor-related anxiolytics